Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to -$2.0 million.

  • Usana Health Sciences' Cash from Operations fell 10663.98% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.5 million, marking a year-over-year decrease of 6119.17%. This contributed to the annual value of $61.0 million for FY2024, which is 1365.92% down from last year.
  • Latest data reveals that Usana Health Sciences reported Cash from Operations of -$2.0 million as of Q3 2025, which was down 10663.98% from $12.2 million recorded in Q2 2025.
  • Usana Health Sciences' 5-year Cash from Operations high stood at $40.5 million for Q4 2022, and its period low was -$2.0 million during Q3 2025.
  • For the 5-year period, Usana Health Sciences' Cash from Operations averaged around $17.0 million, with its median value being $15.5 million (2025).
  • Per our database at Business Quant, Usana Health Sciences' Cash from Operations surged by 36291.04% in 2022 and then tumbled by 10663.98% in 2025.
  • Quarter analysis of 5 years shows Usana Health Sciences' Cash from Operations stood at $19.7 million in 2021, then soared by 105.82% to $40.5 million in 2022, then crashed by 35.69% to $26.0 million in 2023, then plummeted by 77.77% to $5.8 million in 2024, then plummeted by 133.9% to -$2.0 million in 2025.
  • Its Cash from Operations was -$2.0 million in Q3 2025, compared to $12.2 million in Q2 2025 and $15.5 million in Q1 2025.